top of page

Tailored Solutions
to Achieve Goals

Germ-specific diagnosis is hard

but necessary

Inappropriate treatment does not prevent hospitalization (40%, of >65 with pneumonia end up hospitalized), and antibiotic misuse leads to antimicrobial resistance

02

Doctors can diagnose 

pneumonia, but cannot

easily identify the underlying

microorganism

03

By guidelines, they must prescribe broad-spectrum antibiotics to every patient, despite 50% are actually viral

04

Inappropriate treatment does not prevent the patient from ending up hospitalized (cost > $30k /patient)

01

Respiratory tract infections are the most common (~30%) cause of consultation for primary care worldwide

05

Antibiotic overuse leads to antimicrobial resistance (AMR), #1 world cause of death by 2050

Germ-specific diagnosis is hard

but necessary

Inappropriate treatment does not prevent hospitalization (40%, of >65 with pneumonia end up hospitalized), and antibiotic misuse leads to antimicrobial resistance

Antibiotic overuse leads to antimicrobial resistance (AMR), #1 world cause of death by 2050

05

04

Inappropriate treatment does not prevent the patient from ending up hospitalized (cost > $30k /patient)

03

By guidelines, they must prescribe broad-spectrum antibiotics to every patient, despite 50% are actually viral

Doctors can diagnose 

pneumonia, but cannot

easily identify the underlying

microorganism

02

01

Respiratory tract infections are the most common (~30%) cause of consultation for primary care worldwide

01

Respiratory tract infections are the most common (~30%) cause of consultation for primary care worldwide

02

Doctors can diagnose 

pneumonia, but cannot

easily identify the underlying

microorganism

03

By guidelines, they must prescribe broad-spectrum antibiotics to every patient, despite 50% are actually viral

04

Inappropriate treatment does not prevent the patient from ending up hospitalized (cost > $30k /patient)

01

Respiratory tract infections are the most common (~30%) cause of consultation for primary care worldwide

05

Antibiotic overuse leads to antimicrobial resistance (AMR), #1 world cause of death by 2050

Our Team

Jordan Parker

Position / Role

Max Johnson

Position / Role

Drew Carlyle

Position / Role

Morgan James

Position / Role

Any sample works

Compatible with respiratory swab, blood, urine, saliva, stool…

Point of care

Can sit on a desk, no lab required

Fast

Result in 10-15 minutes

Cheap

Device intrinsic value

< $10,000, consumables

< $50 /test

Quantitative

Customizable panel of 50+ viruses, bacteria, and fungi in 1 test

One test to rule them all

Any sample works

Compatible with respiratory swab, blood, urine, saliva, stool…

Point of care

Can sit on a desk, no lab required

Fast

Result in 10-15 minutes

Cheap

Device intrinsic value

< $10,000, consumables

< $50 /test

Quantitative

Customizable panel of 50+ viruses, bacteria, and fungi in 1 test

Point of care

Can sit on a desk, no lab required

Fast

Result in 10-15 minutes

Cheap

Device intrinsic value

< $10,000, consumables

< $50 /test

Quantitative

Customizable panel of 50+ viruses, bacteria, and fungi in 1 test

One test to rule them all

About

We are developing a quantitative analysis capable of detecting all microrganisms in both clinical and non-clinical samples, using a fast and cheap technology which can be deployed at the point of care.

How it works

Competitor approaches

Meet the team

Giulio Deangeli 

MD, PhDc, MBiotech, MMedSci, BEng

2024 - Final year PhD student, University of Cambridge

2021 - «100 number ones» by Forbes

2020 - 5 university courses in parallel, 30/30 GPA

2018 - Harvard HIP Scholarship, ranked in top 5%

2016 - Amgen Scholarship, Cambridge, ranked #1

2013 - World Vice-Champion Neuroscience, IBB

Author of 2 books; papers in Science and in Brain.

Cristiano Peron

MD, PhD

2023 - PhD, University of Oxford

2023 - Clinical Fellow Oxford University Hospital

2021 - Old Silver VC Fellow, Boston

2019 - Medical Doctor, summa cum laude

2018 - Armenise-Harvard Fellowship, Harvard univ.

2017 - IEF Fellowship, Columbia university

Papers in peer reviewed journals

Ulrich Keyser

MEeng, PhD

2016 - Professor of Applied Physics, Cavendish Lab, University of Cambridge

2015 - ERC consolidator grant winner

2010 - ERC starting grant winner

2006 - Emmy Noether award as a group leader, Leipzing University

2006 - Performed the first direct force measurement on DNA in a solid-state nanopore (Nature physics)

Meet the team

bottom of page